Prognostic influence of immunohistochemically detected lymph node micrometastasis and histological subtype in pN0 oesophageal cancer

European Journal of Surgical Oncology

Volumn 35, Issue 6, 2009, Pages 593-599

  Zingg, U ^a   Montani, M ^b   Busch, M ^b   Metzger, U ^b   Went, P ^b   Oertli, D ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b TRIEMLI HOSPITAL   (Switzerland)

Author keywords

Histological subtype; Immunohistochemistry; Isolated tumour cells; Lymph node micrometastasis; Oesophageal cancer

Indexed keywords

ADULT; AGED; ARTICLE; DIAGNOSTIC VALUE; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROMETASTASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS;

EID: 67349108344     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2008.12.001     Document Type: Article

References (32)

1. Siewert R.J., Stein H.J., Feith M., Bruecher B.L.D.M., Bartels H., and Fink U. Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1000 consecutive resections at a single center in the western world. Ann Surg 234 (2001) 360-369
2. Stein H.J., and Siewert J.R. Improved prognosis of resected esophageal cancer. World J Surg 28 (2004) 520-525
3. Orringer M.B., Marshall B., and Iannettoni M.D. Transhiatal esophagectomy: clinical experience and refinements. Ann Surg 230 (1999) 392-403
4. Orringer M.B., Marshall B., Chang A.C., Lee J., Pickens A., and Lau C.L. Two thousand transhiatal esophagectomies. Changing trends, lessons learned. Ann Surg 246 (2007) 363-372
5. Salazar J.D., Doty J.R., Lin J.W., et al. Does cell type influence post-esophagectomy survival in patients with esophageal cancer. Dis Esophagus 11 (1998) 168-171
6. Alexiou C., Khan O.A., Black E., et al. Survival after esophageal resection for carcinoma: the importance of the histologic cell type. Ann Thorac Surg 82 (2006) 1073-1077
7. Khan O.A., Alexiou C., Soomro I., Duffy J.P., Morgan W.E., and Beggs F.D. Pathological determinants of survival in node-negative oesophageal cancer. Br J Surg 91 (2004) 1586-1591
8. Skinner D.B., Ferguson M.K., Soriano A., Little A.G., and Staszak V.M. Selection of operation for esophageal cancer based on staging. Ann Surg 204 (1986) 391-400
9. Li S.H., Wang Z., Liu X.Y., Liu F.Y., Sun Z.Y., and Xue H. Lymph node micrometastasis: a predictor of early tumor relapse after complete resection of histologically node-negative esophageal cancer. Surg Today 37 (2007) 1047-1052
10. Tabira Y., Yasunaga M., Sakaguchi T., Yamaguchi Y., Okuma T., and Kawasuji M. Outcome of histologically node-negative esophageal squamous cell cancer. World J Surg 26 (2002) 1446-1451
11. Jiao X., Eslami A., Ioffe O., et al. Immunohistochemistry analysis of micrometastasis in pre-treatment lymph nodes from patients with esophageal cancer. Ann Thorac Surg 76 (2003) 996-1000
12. Tanabe T., Nishimaki T., Watanabe H., et al. Immunohistochemically detected micrometastasis in lymph nodes from superficial esophageal squamous cell carcinoma. J Surg Oncol 81 (2003) 153-159
13. Sato F., Shimada Y., Li Z., Watanabe G., Maeda M., and Imamura M. Lymph node micrometastasis and prognosis in patients with oesophageal squamous cell carcinoma. Br J Surg 88 (2001) 426-432
14. Natsugoe S., Mueller J., Stein H.J., Feith M., Hoefler H., and Siewert J.R. Micrometastasis and tumor cell microinvolvement of lymph nodes from esophageal squamous cell carcinoma. Cancer 83 (1998) 858-866
15. Vazquez-Sequeiros E., Wang L., Burgart L., et al. Occult lymph node metastasis as a predictor of tumor relapse in patients with node-negative esophageal carcinoma. Gastroenterology 122 (2002) 1815-1821
16. Komukai S., Nishimaki T., Suzuki T., Kanda T., Kuwabara S., and Hatakeyama K. Significance of immunohistochemical nodal micrometastasis as a prognostic indicator in potentially curable oesophageal carcinoma. Br J Surg 89 (2002) 213-219
17. Glickman J.N., Torres C., Wang H.H., et al. The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma. Cancer 85 (1999) 769-778
18. Bonavina L., Incarbone R., Midolo V., Bona D., Ferrero S., and Dall'Asta C. Prognostic significance of lymphatic micrometastasis of esophageal adenocarcinoma. Chir Ital 56 (2004) 189-196
19. Izbicki J.R., Hosch S.B., Pichlmeier U., et al. Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. N Engl J Med 337 (1997) 1188-1194
20. Waterman T.A., Hagen J.A., Peters J.H., DeMeester S.R., Taylor C.R., and DeMeester T.R. The prognostic importance of immunohistochemically detected node metastasis in resected esophageal cancer. Ann Thorac Surg 78 (2004) 1161-1169
21. Matsumoto M., Natsugoe S., Nakashima S., et al. Clinical significance of lymph node micrometastasis of pN0 esophageal squamous cell carcinoma. Cancer Lett 153 (2000) 189-197
22. Komukai S., Nishimaki T., Watanabe H., Ajioka Y., Suzuki T., and Hatakeyama K. Significance of immunohistochemically demonstrated micrometastasis to lymph nodes in esophageal cancer with histologically negative nodes. Surgery 127 (2000) 40-46
23. Hosch S., Kraus J., Scheunemann P., et al. Malignant potential and cytogenetic characteristics of occult disseminated tumor cells in esophageal cancer. Cancer Res 60 (2000) 6836-6840
24. Mandard A.M., Dalibard F., Mandard J.C., et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Cancer 73 (1994) 2680-2688
25. Goddard M.J., Wilson B., and Grant J.W. Comparison of commercially available cytokeratin antibodies in normal and neoplastic adult epithelial and non-epithelial tissues. J Clin Pathol 44 (1991) 660-663
26. Langer I., Guller U., Koechli O.R., et al. Association of the presence of bone marrow micrometastasis with the sentinel lymph node status in 410 early breast cancer patients: results of the Swiss Multicenter Study. Ann Surg Oncol 14 (2007) 1896-1903
27. Hermanek P., Hutter R.V., Sobin L.H., and Wittekind C. Classification of isolated tumor cells and micrometastasis. Cancer 86 (1999) 2668-2673
28. Jiao X., and Krasna M.J. Clinical Significance of micrometastasis in lung and esophageal cancer: a new paradigm in thoracic oncology. Ann Thorac Surg 74 (2002) 278-284
29. Debruyne P.R., Waldman S.A., and Schulz S. Pathological staging and therapy of oesophageal and gastric cancer. Expert Opin Pharmacother 4 (2003) 1083-1096
30. Matsuyama J., Doki Y., Yasuda T., et al. The effect of neoadjuvant chemotherapy on lymph node micrometastases in squamous cell carcinoma of the thoracic esophagus. Surgery 141 (2007) 570-580
31. Prenzel K.L., Koenig A., Schneider P.M., et al. Reduced incidence of nodal micrometastasis after major response to neoadjuvant chemoradiation in locally advanced esophageal cancer. Ann Surg Oncol 14 (2006) 954-959
32. Schneider P.M., Baldus S.E., Metzger R., et al. Histomorphologic tumor regression and lymph node metastasis determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer. Ann Surg 242 (2005) 684-692